167 related articles for article (PubMed ID: 34679461)
1. Diagnostic Performance of KLCA-NCC 2018 Criteria for Hepatocellular Carcinoma Using Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis.
Kim DH; Kim B; Youn SY; Kim H; Choi JI
Diagnostics (Basel); 2021 Sep; 11(10):. PubMed ID: 34679461
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Performance of LI-RADS v2018 versus KLCA-NCC 2018 Criteria for Hepatocellular Carcinoma Using Magnetic Resonance Imaging with Hepatobiliary Agent: A Systematic Review and Meta-Analysis of Comparative Studies.
Shin J; Lee S; Yoon JK; Son WJ; Roh YH; Chung YE; Choi JY; Park MS
Gut Liver; 2023 May; 17(3):466-474. PubMed ID: 36317516
[TBL] [Abstract][Full Text] [Related]
3. Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging.
Lee S; Kim SS; Chang DR; Kim H; Kim MJ
Clin Mol Hepatol; 2020 Jul; 26(3):340-351. PubMed ID: 32492765
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of the 2022 KLCA-NCC criteria for hepatocellular carcinoma on magnetic resonance imaging with extracellular contrast and hepatobiliary agents: comparison with the 2018 KLCA-NCC criteria.
Yoon JK; Lee S; Hwang JA; Lee JE; Kim SS; Kim MJ
J Liver Cancer; 2023 Mar; 23(1):157-165. PubMed ID: 37384026
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Performance of 2018 KLCA-NCC Practice Guideline for Hepatocellular Carcinoma on Gadoxetic Acid-Enhanced MRI in Patients with Chronic Hepatitis B or Cirrhosis: Comparison with LI-RADS Version 2018.
Lee SM; Lee JM; Ahn SJ; Kang HJ; Yang HK; Yoon JH
Korean J Radiol; 2021 Jul; 22(7):1066-1076. PubMed ID: 33739633
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Korean Liver Cancer Association-National Cancer Center 2018 Criteria for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using Magnetic Resonance Imaging.
Lee S; Kim MJ
J Liver Cancer; 2020 Sep; 20(2):120-127. PubMed ID: 37384315
[TBL] [Abstract][Full Text] [Related]
7. Comparison of guidelines for diagnosis of hepatocellular carcinoma using gadoxetic acid-enhanced MRI in transplantation candidates.
Jeon SK; Lee JM; Joo I; Yoo J; Park JY
Eur Radiol; 2020 Sep; 30(9):4762-4771. PubMed ID: 32333148
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the diagnostic performance of imaging criteria for HCCs ≤ 3.0 cm on gadoxetate disodium-enhanced MRI.
Byun J; Choi SH; Byun JH; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
Hepatol Int; 2020 Jul; 14(4):534-543. PubMed ID: 32314171
[TBL] [Abstract][Full Text] [Related]
9. Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association-National Cancer Center 2022 Criteria.
Yoon JK; Han DH; Lee S; Choi JY; Choi GH; Kim DY; Kim MJ
Cancer Res Treat; 2023 Jul; 55(3):939-947. PubMed ID: 36791769
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of current guidelines for hepatocellular carcinoma diagnosis on gadoxetic acid-enhanced MRI in at-risk patients.
Park SH; Shim YS; Kim B; Kim SY; Kim YS; Huh J; Park JH; Kim KW; Lee SS
Eur Radiol; 2021 Jul; 31(7):4751-4763. PubMed ID: 33389037
[TBL] [Abstract][Full Text] [Related]
11. Role of Contrast-Enhanced Ultrasound as a Second-Line Diagnostic Modality in Noninvasive Diagnostic Algorithms for Hepatocellular Carcinoma.
Kang HJ; Lee JM; Yoon JH; Han JK
Korean J Radiol; 2021 Mar; 22(3):354-365. PubMed ID: 33236540
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of Liver Imaging Reporting and Data System treatment response algorithm: a systematic review and meta-analysis.
Youn SY; Kim DH; Choi SH; Kim B; Choi JI; Shin YR; Oh SN; Rha SE
Eur Radiol; 2021 Jul; 31(7):4785-4793. PubMed ID: 33409795
[TBL] [Abstract][Full Text] [Related]
13. LI-RADS Major Features on MRI for Diagnosing Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Shin J; Lee S; Yoon JK; Chung YE; Choi JY; Park MS
J Magn Reson Imaging; 2021 Aug; 54(2):518-525. PubMed ID: 33638582
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of MRI for HCC according to contrast agent type: a systematic review and meta-analysis.
Kim DW; Choi SH; Kim SY; Byun JH; Lee SS; Park SH; Kim KW
Hepatol Int; 2020 Dec; 14(6):1009-1022. PubMed ID: 33146841
[TBL] [Abstract][Full Text] [Related]
15. Emerging Role of Hepatobiliary Magnetic Resonance Contrast Media and Contrast-Enhanced Ultrasound for Noninvasive Diagnosis of Hepatocellular Carcinoma: Emphasis on Recent Updates in Major Guidelines.
Kim TH; Yoon JH; Lee JM
Korean J Radiol; 2019 Jun; 20(6):863-879. PubMed ID: 31132813
[TBL] [Abstract][Full Text] [Related]
16. Magnetic Resonance Imaging for Surveillance of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Kim DH; Choi SH; Shim JH; Kim SY; Lee SS; Byun JH; Kim KW; Choi JI
Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34574006
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of LI-RADS for MRI and CT detection of HCC: A systematic review and diagnostic meta-analysis.
Liang Y; Xu F; Guo Y; Lai L; Jiang X; Wei X; Wu H; Wang J
Eur J Radiol; 2021 Jan; 134():109404. PubMed ID: 33276248
[TBL] [Abstract][Full Text] [Related]
18. MRI Features for Predicting Microvascular Invasion of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Hong SB; Choi SH; Kim SY; Shim JH; Lee SS; Byun JH; Park SH; Kim KW; Kim S; Lee NK
Liver Cancer; 2021 Apr; 10(2):94-106. PubMed ID: 33981625
[TBL] [Abstract][Full Text] [Related]
19. Liver imaging reporting and data system category M: A systematic review and meta-analysis.
Kim DH; Choi SH; Park SH; Kim KW; Byun JH; Kim SY; Lee SS; Shin YM; Won HJ; Kim PN
Liver Int; 2020 Jun; 40(6):1477-1487. PubMed ID: 32129541
[TBL] [Abstract][Full Text] [Related]
20. Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update.
Kim TH; Kim SY; Tang A; Lee JM
Clin Mol Hepatol; 2019 Sep; 25(3):245-263. PubMed ID: 30759967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]